FTV heads into the back half of August with short sellers quietly adding exposure and the stock down nearly 4% on the month — a reset that brings Q3 earnings season back into focus.
The short interest story is the standout this week. Bears have rebuilt positions steadily since late July, when short interest bottomed near 10.4 million shares. It has climbed roughly 37% from that trough to 14.2 million shares, or 4.5% of free float — the highest level in the 30-day window. The move is methodical rather than explosive: shorts added about 5% in the past week alone, and the pace has held fairly consistent across eight straight sessions. What makes this notable is the context: the stock just printed an ugly Q2 reaction, falling nearly 9% on July 29, and bears appear to have used the subsequent partial recovery as a re-entry point.
The lending market, however, does not support a squeeze narrative. Borrow costs have eased 20% over the past week to just 0.40% — a low, almost frictionless rate that costs shorts essentially nothing to maintain their positions. Availability sits near 976%, meaning there are roughly ten times as many shares available to borrow as are currently borrowed. That is a loose lending market by any measure and well above the 52-week tightest reading of 373%. Options positioning is similarly relaxed. The put/call ratio of 1.18 is just below its 20-day average of 1.20, with a z-score of -0.60 — meaning options traders are no more defensive than usual. The positioning picture is rebuilding shorts in a frictionless borrow market, with no hedging urgency visible in derivatives.
The Street's view on FTV is cautious but not bearish. Most analysts sit in hold or neutral territory: Truist maintained a Hold with a $68 target after the Q2 print, Morgan Stanley holds Equal-Weight with a $59 target, and JPMorgan carries an Underweight at $64. Argus Research is the outlier on the upside — reiterated Buy at $68 this week — while the mean price target across the analyst base of $64.42 implies modest upside from the current $59.45. That gap has narrowed considerably from earlier in the year, reducing the Street's cushion. Valuation multiples have compressed alongside the stock: the P/E has drifted down 0.31 points over 30 days, and EV/EBITDA has slipped modestly too, though at roughly 15.9x EBITDA the stock is not cheap. The forward EPS growth score of 76 out of 100 is a genuine bright spot, pointing to reasonable earnings estimates for next year, but near-term momentum scores are middling — EPS momentum over 30 and 90 days both rank below the median.
The July 29 earnings reaction deserves attention heading into October. The stock fell 8.75% on the day and gave back an additional point over the subsequent week — a meaningful punishment for what the market judged as a disappointing print. The Q3 event is currently pencilled for October 28. The prior quarter's selloff was severe enough to trigger a wave of short rebuilding that is still running: shorts went from roughly 11.9 million shares at the end of July to 14.2 million by August 18. With the stock now trading near levels seen before the Q2 report, bears appear to be positioning for a repeat rather than a recovery.
The institutional base remains concentrated and mostly stable. Dodge & Cox leads with 14.6% of shares, adding around 823,000 shares in Q2. T. Rowe Price built a more aggressive add of 2.7 million shares. Nordea Investment Management added 2.5 million shares in the same window. The contrast between institutional accumulation and short rebuilding creates a genuine tension in the register — the same stock that large active managers bought on weakness is the one shorts are piling back into ahead of Q3.
What to watch: whether short interest continues to climb toward the August highs above 14.9 million shares seen in early August, and whether the next leg of the Q3 setup shifts the borrow market tighter as October approaches.
See the live data behind this article on ORTEX.
Open FTV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
